ASArseny A. Semenov

Arseny A. Semenov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Arseny A. Semenov has a total of 119 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Features of Asymptomatic Pheochromocytoma/Paraganglioma Based on Clinical-Laboratory Examination and Computed Tomography

    by D. V. Rebrova, S. N. Fogt, R. A. Chernikov, I. V. Sleptsov, E. A. Fedorov, I. K. Chinchuk, Sh. Sh. Shikhmagomedov, N. V. Vorokhobina, E. A. Zgoda, A. A. Semenov, et al.

    BACKGROUND : Although pheochromocytomas and paragangliomas (PPGLs) classically present with distinct clinical signs, there is a category of patients with asymptomatic disease course. Despite the absence of clinical manifestations, these patients retain the risk of life-threatening hypertensive crisis and other cardiovascular complications. The clinical, laboratory, and imaging characteristics of asymptomatic PPGLs remain insufficiently studied and are of significant scientific and practical interest. AIM : To analyze the clinical, laboratory, and imaging characteristics of asymptomatic PPGLs compared to symptomatic ones. MATERIALS AND METHODS : The analysis included 347 patients with histologically confirmed PPGL who underwent surgery at the Saint Petersburg State University Hospital. Retrospective analysis encompassed demographic data, medical history (primary and comorbid conditions), laboratory findings, and computed tomography (CT) data. RESULTS: The PPGLs patient cohort included 45 cases without clinical signs of catecholamine hypersecretion. The asymptomatic subgroup, compared to symptomatic patients, exhibited younger age (43 [33; 51] vs. 48 [37; 57] years); smaller maximum tumor size (34 [27; 53] vs. 45 [34; 60] mm); lower metanephrine/normetanephrine ratio (0.29 [0.10; 0.79] vs. 0.51 [0.09; 1.23]). CT imaging revealed slightly higher radiodensity values in asymptomatic PPGLs during arterial, venous, and delayed phases compared to symptomatic tumors. However, absolute and relative washout percentages did not differ significantly. CONCLUSION : The younger age and smaller tumor size in asymptomatic PPGL patients suggest earlier detection of the disease compared to symptomatic cases. The lower metanephrine/normetanephrine ratio may indicate a higher prevalence of the norepinephrine-secreting phenotype in asymptomatic PPGLs. No pronounced differences were found in imaging characteristics between asymptomatic and symptomatic tumors.

  • Core needle biopsy in the diagnosis of anaplastic thyroid carcinoma and other aggressive forms of head and neck tumours

    by N. I. Timofeeva, R. A. Chernikov, I. V. Sleptsov, S. L. Vorobjev, A. A. Semenov, A. G. Kulyash, M. U. Amelin

    BACKGROUND: The most aggressive head and neck malignant tumours are still a great medical and social problem due to the known difficulties both at the diagnostic stage and in the choice of molecular-personalized treatment strategy. The most rapid and accurate morphological (histological, immunohistochemical, molecular genetic) diagnosis is of fundamental importance. Fine-needle aspiration biopsy is often insufficient for these tasks, particularly in large, rapidly growing tumors and after radiotherapy, when pronounced fibrosis reduces the diagnostic yield of cytology. An alternative to incisional biopsy — which carries anesthetic risks in patients with bulky cervical tumor masses — is core needle biopsy, which enables procurement of representative tissue cores for comprehensive histologic, immunohistochemical, and molecular-genetic studies within a short timeframe. AIM: To evaluate the diagnostic yield, clinical utility, and safety of core needle biopsy in the workup of anaplastic thyroid carcinoma, lymphoproliferative disorders, and other aggressive neck tumors, including the feasibility of performing valid histologic, immunohistochemical, and molecular-genetic assays on the obtained material and the impact of the results on initial therapeutic decision-making. MATERIALS AND METHODS: In the period 2017–2025, a total of 131 core needle biopsies were performed at Saint-Petersburg State University for patients with anaplastic thyroid carcinoma, lymphoproliferative diseases and other aggressive tumours. The technique of core needle biopsy of neck tumours is described in detail. RESULTS: Among all patients who underwent core needle biopsy, on the basis of histological and immunohistochemical methods the diagnosis of anaplastic carcinoma was established in 79 patients (60.3%), lymphoma — in 22 patients (16.8%), other tumours and non-tumours — in 30 patients (22.9%). According to the data of genetic studies, BRAFV600E mutation was detected in 27 patients with anaplastic carcinoma, one mutation in NRAS codon 61 of Q61K type (181C>A); one case of mutation in NTRK3 gene (ex15) was detected. CONCLUSION: Core needle biopsy of thyroid, neck tumours and neck lymph nodes is a simple, minimally invasive and effective intervention with high informative and diagnostic value. The advantage of this method is the possibility of obtaining sufficient material to study the structural and cellular characteristics of the tumour, to perform valid immunohistochemical and molecular genetic studies.

  • Open Access

    Pheochromocytoma in Neurofibromatosis Type 1

    by D. V. Rebrova, O. I. Loginova, S. L. Nepomnyashchaya, A. R. Bakhtiyarova, V. F. Rusakov, L. M. Krasnov, E. A. Fedorov, I. K. Chinchuk, Sh. Sh. Shikhmagomedov, E. N. Imyanitov, et al.

    Neurofibromatosis type 1 is a hereditary disease with a wide variability of clinical manifestations, from the almost complete absence of typical symptoms to a multisystem lesion of the body. One of the possible clinical manifestations of this pathology is a pheochromocytoma — a tumor of the adrenal gland with the possible development of considerable cardiovascular complications. The article describes four cases of patients with pheochromocytoma as part of familial neurofibromatosis type 1, differing in clinical course from asymptomatic form to vivid paroxysmal manifestations. At the same time, the presence and degree of arterial hypertension did not correlate with the level of metanephrines and the size of the pheochromocytoma. 3 out of 4 patients have a hereditary history of neurofibromatosis type 1. In 1 out of 4 cases, simultaneous bilateral damage to the adrenal glands was noted, while the radiation characteristics of pheochromocytomas, both with computed tomography and CT/PET with 18-FDG, differed from the "classic" ones. An objective examination with the identification of "erased" signs of neurofibromatosis type 1 made it possible to establish the diagnosis of bilateral pheochromocytoma even with questionable laboratory and imaging data. Knowledge of clinical manifestations, timely diagnosis of neurofibromatosis type 1, comprehensive treatment and subsequent regular monitoring of patients, as well as examination of blood relatives can significantly improve prognosis and survival.


  • Open Access

    Linguistic and cultural adaptation of the POSAS 3.0 questionnaire for assessing the quality of linear scar formation and its testing in the Russian patient population after surgery of thyroid gland diseases

    by S. O. Belozerov, T. I. Ionova, T. P. Nikitina, R. A. Chernikov, A. A. Semenov, Sh. Sh. Shikhmagomedov, G. V. Kantariia, N. А. Gorskaya, G. S. Kuli-Zadeh, M. Mladenovic, et al.

    BACKGROUND: When assessing the effectiveness of scar treatment, it is important to consider both the specialist’s assessment of the scar characteristics and the patient’s self-assessment of their condition. The Patient and Observer Scar Assessment Scale (POSAS) is a questionnaire recommended by international guidelines for evaluating the quality of scar formation, including after surgical treatment.AIM: To perform linguistic and cultural adaptation of the Russian version of the POSAS 3.0 questionnaire and to test it in the Russian patient population with various thyroid pathologies.MATERIALS AND METHODS: The linguistic and cultural adaptation of the POSAS 3.0 questionnaire was performed in accordance with modern international recommendations. It included the procedure of forward and back translations, testing of the Russian versions via patients’ interviews, expert evaluation of Russian version by specialists and decentering.RESULTS: The test version of the questionnaire was tested on 15 patients with various thyroid pathologies. Based on the interviews, an acceptable indicator of the external validity of the Russian version of the questionnaire was established. According to the survey of specialists (n = 9), its content validity was confirmed.CONCLUSION: The linguistic and cultural adaptation process resulted in the final Russian version of the POSAS 3.0 questionnaire, which is equivalent to the original version and corresponds to the ethno-linguistic characteristics of the population. The use of the POSAS 3.0 questionnaire in research and clinical practice is possible after assessment of psychometric properties of these tools.


  • Open Access

    A unique case of severe ACTH-dependent Cushing’s syndrome due to ectopic corticotropin production by medullary thyroid carcinoma

    by N. I. Timofeeva, R. A. Chernikov, I. V. Sleptsov, V. F. Rusakov, D. V. Rebrova, S. L. Vorobyev, T. S. Pridvizhkina, A. A. Semenov, M. A. Alexeev, A. U. Kulikov

    Medullary thyroid carcinoma is a rare aggressive tumor of thyroid gland. Due to its neuroendocrine origine medullary thyroid carcinoma can be the source of ectopic production of different peptides and hormones. We describe a unique case of severe ACTH-dependent Cushing’s syndrome due to ectopic corticotropin production by medullary thyroid carcinoma in a male patient of 39 years old with calcitonin level more than 4000 pg/ml (<11,8), thyroid nodule, multiple neck jugular and central lymphnodes. The potassium level was 1,34 mmol/l (3,5–5,1), hypercortisolemia up to 1613,2 nmol/l (185–624) with elevated level of ACTH up to 24,7 pmol/l (1,03–10,74). After the correction of water and electrolytes disorders an operation was performed — thyroidectomy, central and lateral neck dissection. Postoperative calcitonin decreased to 126 pg/ml (<11,8), calcium and parathormone blood levels remained normal. The potassium level didn’t decrease without any pharmacological treatment. There was a sharp fall in postoperative blood levels of cortisol and ACTH. The hormonal replacement treatment with hydrocortisone was induced. Morphological examination showed medullary carcinoma with ACTH production in tumor nodule, with metastatic neck lymph nodes. Thus this is a rare case and successful treatment of patient with severe hypercortisolism by thyroidectomy and neck lymphnodes dissection.


  • OPERATION DURATION ESTIMATION BY ENSEMBLE METHODS OF DECISION TREES

    by M.S. Parshakova, A.A. Semenov, M.B. Laskin

    With the multiplied data flow and information accumulation in medical organizations, new opportunities arise to process data and extract meaningful information from them for both therapeutic and organizational purposes. The peculiarity of medical data is the contradiction between the obvious cause-and-effect relationships between influencing factors and target indicators and, often, the complete lack of opportunities to build functional dependencies between them. In this case, application of machine learning methods and algorithms can be a solution to this contradiction. The article considers the task of predicting the duration of surgical operations according to a given set of influencing factors for the purposes of optimal loading of operating units of a medical organization. The data for the study was provided by one of the leading clinics in its field in St. Petersburg.


  • Open Access

    Adrenocortical Cancer. Results of Examination of Patients at the Clinic of High Medical Technologies

    by Дина Владимировна Реброва, Илья Валерьевич Слепцов, Роман Анатольевич Черников, Игорь Константинович Чинчук, Владимир Федорович Русаков, Леонид Михайлович Краснов, Елисей Александрович Федоров, Арсений Андреевич Семенов, Татьяна Вячеславовна Савельева, Ольга Ивановна Логинова, et al.

    Materials and Methods. The article describes the results of the examination of 76 patients with adrenocortical cancer (ACC), who have undergone surgery in the in-patient facility of the N.I. Pirogov Clinic of High Medical Technologies of St. Petersburg State University. ACC was diagnosed from 2009 to 2020. Patient demographic data, baseline disease characteristics, tumor hormonal activity, and computed tomography (CT) data were described. Results. Overall, the data obtained were consistent with the international literature with respect to age at onset of the disease (median age 45 years), the ratio of females to males (3:1), and the incidence of hypercortisolism (48.8 %). It was found that the combination of radiographic density ≤ 20 HU and mass size less than 4 cm does not exclude all cases of ACC. According to the findings 2 (3.3 %) of 65 patients would not be diagnosed if the above criteria had been used. Within the CT data analysis, about one-third of patients showed no increase in the standard thresholds for absolute and relative percentage washout (RPW) that defines malignancy. The results analysis revealed that the subgroup of patients with Cushing syndrome had a statistically significant increase in contrast washout rates. Conclusion. Overall, the findings in ACC patients in the studied population are consistent with the literature data. The study results suggest that the diagnostic value of contrast washout parameters for differential diagnosis of ACC is limited, especially in patients with small tumors and with Cushing syndrome. According to the data obtained, the most reliable criterion for excluding ACR is native tumor radiodensity < 10 HU; the use of this criterion made it possible to exclude all cases of ACC. Материалы и методы. В настоящей статье приведено описание результатов обследования 76 пациентов с адренокортикальным раком (АКР), прооперированных в стационаре Петербургского государственного университета. Диагноз АКР был установлен с 2009 по 2020 гг. Описаны демографические характеристики пациентов, основные характеристики заболевания, гормональная активность опухоли, данные компьютерной томографии (КТ). Результаты. В целом получены данные, согласующиеся с международной литературой, в отношении возраста при дебюте заболевания (медиана возраста — 45 лет), соотношения лиц женского и мужского пола (3:1), частоты гиперкортизолизма (48,8 %). Обнаружено, что сочетание рентгенологической плотности ≤ 20 HU и размера новообразования менее 4 см не исключает все случаи АКР, согласно полученным данным, у 2 (3,3 %) из 65 пациентов при использовании указанных критериев заболевание было бы пропущено. В рамках анализа данных КТ примерно у трети пациентов не обнаружено повышения стандартных порогов абсолютного и относительного процентов вымывания контраста для определения злокачественности опухоли. При анализе результатов было обнаружено, что в подгруппе пациентов с манифестным синдромом Иценко — Кушинга, при сравнении с остальными, имеет место статистически значимое повышение показателей вымывания контраста. Заключение. В целом полученные данные у пациентов с АКР в исследованной популяции согласуются с литературными. Результаты исследования свидетельствуют о том, что диагностическая ценность определения показателей вымывания контраста для дифференциальной диагностики АКР ограничена, особенно при небольших размерах новообразования и при синдроме Иценко - Кушинга. Согласно полученным данным, наиболее надежным критерием исключения АКР является нативная рентгенологическая плотность < 10 HU, использование этого критерия позволило исключить АКР во всех случаях.

  • Open Access

    Metastatic pheochromocytoma in multiple endocrine neoplasia type 2A

    by D. V. Rebrova, V. F. Rusakov, L. M. Krasnov, E. A. Fedorov, I. K. Chinchuk, N. V. Vorokhobina, S. S. Shikhmagomedov, A. A. Semenov, R. A. Chernikov, I. V. Sleptsov, et al.

    Pheochromocytoma (PHEO) currently is considered to be malignant due to metastatic potential. One of the most common familial forms of PHEO is multiple endocrine neoplasia syndrome (MEN) type 2. The penetrance of PHEO in MEN2 syndrome is up to 50% of cases. It may be one- or two-sided, but metastases occur extremely rare. The fact that in majority of cases of MEN2 syndrome the source of distant metastases is medullary thyroid carcinoma (MTC) complicates differential diagnosis in case of PHEO metastasis.Isolated cases of PHEO with metastases to the lymph nodes, lungs, liver, bones, brain in MEN2 patients were described. In the available literature, we have found a description of 31 cases of metastatic PHEO in MEN2 syndrome. The available data of those cases is presented as a table in the article.We present a description of a 40-year-old woman with MEN2A syndrome (mutation of the RET proto-oncogene p.Cys634Tyr), with a history of twice-performed surgical treatment of MTC, with daily crises of arterial hypertension accompanied by vegetative symptoms, with a giant bilateral PHEO (up to 200 m on the right and up to 150 mm on the left) with synchronous large metastasis (up to 50 mm) into the pubic bone with the destruction. The patient underwent several surgeries: bilateral adrenalectomy, then a bilateral revision of the neck, removal of the right upper and right lower parathyroid glands, residual thyroid tissue, then resection of the right pubic bone with a tumor.

  • Open Access

    Metastatic risk factors in pheochromocytoma/paraganglioma

    by D. V. Rebrova, O. I. Loginova, S. L. Vorobyev, N. V. Vorokhobina, E. S. Kozorezova, F. A. Indeykin, T. V. Savelyeva, I. V. Sleptsov, R. A. Chernikov, E. A. Fedorov, et al.

    Currently, all pheochromocytoma/paraganglioma (PPGLs) are considered malignant due to metastatic potential. Consequently, PPGLs are divided into «metastatic» and «non-metastatic». Metastatic PPGLs can be with synchronous metastasis (metastases appear simultaneously with the identified primary tumor) or metachronous (metastases develop after removal of the primary tumor). The term metastatic PPGLs is not used in the presence of tumor invasion into surrounding organs and tissues, without the presence of distant metastases of lymphogenic or hematogenic origin. It is generally believed that about 10% of pheochromocytomas and about 40% of sympathetic paragangliomas have metastatic potential. On average, the prevalence of PPGLs with the presence of metastases is 15–20%. Risk factors for metastatic PPGLs are widely discussed in the literature, the most significant of which are groups of clinical, morphological and genetic characteristics. The review presents a discussion of such risk factors for metastatic PPGLs as age, localization and type of hormonal secretion of the tumor, the size and growth pattern of the adrenal lesion, the presence of necrosis and invasion into the vessels, the tumor capsule surrounding adipose tissue, high cellular and mitotic activity, Ki-67 index, expression of chromogranin B and S100 protein, the presence of genetic mutations of three main clusters (pseudohypoxia, kinase signaling and Wnt signaling).Over the past two decades, a number of authors have proposed various predictor factors and scales for assessing a probability of metastatic PPGLs. The review contains detailed description and comparison of sensitivity and specificity of such predictor scales as PASS, GAPP, M-GAPP, ASES and COPPS.


  • Open Access

    ФАКТОРЫ РИСКА ПОВТОРНЫХ ОПЕРАЦИЙ ПО ПОВОДУ ПЕРВИЧНОГО ГИПЕРПАРАТИРЕОЗА В СРЕДНИЕ СРОКИ НАБЛЮДЕНИЯ

    by Д. М. Бузанаков, И. В. Слепцов, Р. А. Черников, А. А. Семенов, К. Ю. Новокшонов, Ю. В. Карелина, В. А. Макарьин, А. А. Успенская, Н. И. Тимофеева, Н. А. Горская, et al.